FAP+ gastric cancer mesenchymal stromal cells via paracrining INHBA and remodeling ECM promote tumor progression
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2024.113697 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Ting Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Digestive Disease Institute & Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, J…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Mesenchymal Stem Cells, Extracellular Matrix, Tumor Microenvironment. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Jiangsu Province Natural Science Foundation, Innovative Research Group Project of the National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Gastric cancer (GC) mesenchymal stromal cells (GCMSCs) are the predominant components of the tumor microenvironment (TME) and play a role in the occurrence, development, and metastasis of tumors. However, GCMSCs exhibit phenotypic and functional heterogeneity. The key population of GCMSCs which are vital to tumor progression remains elusive. The expression of fibroblast activation protein (FAP) in gastric cancer was analyzed and verified using clinical pathology data and single-cell RNA sequencing database of gastric cancer patients. FAP positive GCMSCs (FAP+ GCMSCs) were isolated via flow cytometry and characterized through transcriptomic sequencing. The impact of conditioned medium from FAP+ GCMSCs on gastric cancer cell lines was assessed using Enzyme-linked immunosorbent assay (ELISA) and Western blot analyses. Additionally, immunohistochemistry (IHC) and Masson's trichrome staining were employed to explore the association between FAP+ GCMSCs and extracellular matrix (ECM) deposition in gastric cancer tissues. Our study demonstrates that FAP is predominantly expressed in the mesenchymal stromal cells within the gastric cancer milieu. FAP+ GCMSCs exhibited enhanced proliferation, migration, contraction, and tumor-promoting capabilities compared to their FAP- counterparts. These cells significantly increased proliferation and migration of gastric cancer cells through the paracrine secretion of Inhibin Subunit Beta A (INHBA) and activation of the SMAD2/3 signaling pathway. Moreover, FAP+ GCMSCs also induced collagen deposition in ECM and then up-regulated invasion and stemness of GC cells. Mechanistically, this process was mediated by the interaction of collagen with Integrin Subunit Beta 1 (ITGB1), triggering the phosphorylation of Focal Adhesion Kinase (FAK) and Yes Associated Transcriptional Regulator (YAP). Our findings reveal that FAP+ GCSMCs enhanced the GC progression via releasing cytokine INHBA and remodeling ECM providing a theoretical basis for further exploration of tumor stromal-targeting therapy of gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Digestive Disease Institute & Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, China; School of Medicine, Jiangsu University, Zhenjia…
- School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, 212013, China.
- Department of Clinical Laboratory, Affiliated Kunshan Hospital of Jiangsu University, Suzhou, Jiangsu Province, 215300, China.
- Department of Gastrointestinal Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, China.
- Department of Oncology, Digestive Disease Institute & Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, China. Electronic address: deqiang_wang@aliyun.com.
Förderung
- Jiangsu Province Natural Science Foundation
- Innovative Research Group Project of the National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Liu, T., Huang, C., Sun, L., Chen, Z., Ge, Y., Ji, W., Chen, S., Zhao, Y., Wang, M., Wang, D., & Zhu, W. (2025). FAP+ gastric cancer mesenchymal stromal cells via paracrining INHBA and remodeling ECM promote tumor progression. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113697
Vancouver
Liu T, Huang C, Sun L, Chen Z, Ge Y, Ji W, et al. FAP+ gastric cancer mesenchymal stromal cells via paracrining INHBA and remodeling ECM promote tumor progression. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2024.113697
BibTeX
@article{Liu2025,
author = {Liu, Ting and Huang, Chao and Sun, Li and Chen, Zhihong and Ge, Yan and Ji, Weimeng and Chen, Shihan and Zhao, Yuanyuan and Wang, Mei and Wang, Deqiang and Zhu, Wei},
title = {FAP+ gastric cancer mesenchymal stromal cells via paracrining INHBA and remodeling ECM promote tumor progression},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2024.113697}
}
EUVIMED